Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex.

Annals of neurology·2025

Same author

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Neuropathology and applied neurobiology·2012

Same author

Neuropathologic evidence of endothelial changes in cerebral small vessel disease.

Neurology·2011

Same author

Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2010

Same author

Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis.

Psychopharmacology·2008

Same author

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.

Psychopharmacology·2007

Same journal

American academy of neurology annual meeting.

International MS journal·2011

Same journal

Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.

International MS journal·2011

Same journal

The clinical usefulness of routine MRI assessment.

International MS journal·2011

Same journal

Acute Psychosis as the Initial Presentation of MS: A Case Report.

International MS journal·2011

Same journal

Russell Brains Review of MS.

International MS journal·2011

Same journal

Epstein-Barr Virus and MS:Causality or Association?

International MS journal·2011

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

MS: is it one disease?

International MS Journal

|August 13, 2009

Summary

This summary is machine-generated.

Multiple Sclerosis (MS) research struggles to confirm distinct pathological subtypes, despite earlier suggestions. This ongoing debate impacts understanding MS and developing effective treatments.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: Jun 21, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

Neuroimmunology
Neuropathology

Background:

Multiple sclerosis (MS) pathology is recognized as heterogeneous, often attributed to lesion age.
A 2000 hypothesis proposed four distinct pathological MS subtypes, which has faced challenges in replication.
Recent studies on neuromyelitis optica suggest it is distinct from MS, highlighting the need for clarity in neuroinflammatory diseases.

Discussion:

Inconsistent findings challenge the existence of distinct pathological subtypes within the multiple sclerosis disease spectrum.
The heterogeneity of MS pathology remains a key area of investigation for understanding disease mechanisms.
Comparing MS with conditions like neuromyelitis optica, now accepted as distinct, underscores the need for definitive classification.

Key Insights:

Replication attempts have failed to confirm the proposed four pathological subtypes of multiple sclerosis.
The distinct nature of neuromyelitis optica from MS provides a contrasting example of successful disease differentiation.
Resolving immunopathological controversies in MS is critical for advancing diagnostic and therapeutic strategies.

Outlook:

Future consensus studies may bring greater consistency to the reporting of MS pathology.
Further research is needed to clarify the molecular pathology and potential subtypes of MS.
Establishing clear pathological definitions is essential for targeted therapies and improved patient outcomes.